How to Get Upstaza (Eladocagene Exuparvovec) Approved by UnitedHealthcare in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Upstaza Covered by UnitedHealthcare in North Carolina

To get Upstaza (eladocagene exuparvovec) approved by UnitedHealthcare in North Carolina, you need: (1) genetic confirmation of biallelic DDC mutations from a CLIA-certified lab, (2) biochemical evidence (AADC enzyme activity <50% normal or abnormal CSF profile), and (3) treatment at a UnitedHealthcare-approved Center of Excellence. Submit the OptumRx Prior Authorization Form through the provider portal or fax to 1-844-403-1027. If denied, North Carolina's Smart NC external review program has an 81.7% overturn rate for specialty drug appeals. Call Smart NC at 1-855-408-1212 for free advocacy support.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Verify Your Coverage
  3. Gather Required Documentation
  4. Submit Your Prior Authorization Request
  5. Follow-Up and Timeline Expectations
  6. If You Need to Provide Additional Information
  7. If Your Request is Denied
  8. North Carolina Appeals Process
  9. Renewal and Re-authorization
  10. Quick Reference Checklist

What This Guide Covers

This guide helps patients with AADC deficiency and their healthcare teams navigate UnitedHealthcare's prior authorization process for Upstaza (eladocagene exuparvovec), known as Kebilidi in the US. We'll walk through the specific requirements, documentation needs, and appeal options available to North Carolina residents.

Upstaza is a one-time gene therapy that requires stereotactic surgery at specialized centers. The treatment costs several million dollars, making prior authorization critical for coverage approval.

Before You Start: Verify Your Coverage

Check Your Plan Type

First, confirm you have a UnitedHealthcare plan that covers specialty medications. Call member services at 1-800-711-4555 to verify:

  • Your plan includes specialty pharmacy benefits through OptumRx
  • Gene therapy coverage is included (not excluded as experimental)
  • Whether Upstaza requires prior authorization (it typically does)

Verify Network Status

Treatment must occur at a UnitedHealthcare-approved Center of Excellence. Contact PTC Therapeutics through their website or call member services to confirm which centers in North Carolina are in-network for gene therapy services.

Understand Your Benefits

Gene therapy may be covered under your medical benefit rather than pharmacy benefit. Ask UnitedHealthcare specifically about:

  • Your deductible and out-of-pocket maximum
  • Coinsurance rates for gene therapy
  • Whether the treatment requires a referral

Gather Required Documentation

Essential Clinical Documentation

Genetic Testing Results

  • Biallelic DDC gene mutations confirmed by CLIA-certified laboratory
  • Must show specific mutations, not just "positive" results
  • Results should be within the last 12 months if possible

Biochemical Evidence

  • AADC enzyme activity levels showing <50% of normal range, OR
  • Cerebrospinal fluid (CSF) neurotransmitter profile showing abnormalities
  • Both tests must be from CLIA-certified laboratories

Clinical Notes

  • Documentation of AADC deficiency symptoms and progression
  • Patient age confirmation (must be ≥18 months)
  • Neurological assessments and imaging results

Administrative Documents

  • Current UnitedHealthcare insurance card
  • Complete patient demographics and policy information
  • Letter of medical necessity from the ordering physician
  • Treatment center confirmation of UnitedHealthcare network participation

Submit Your Prior Authorization Request

OptumRx Prior Authorization Form

UnitedHealthcare processes Upstaza requests through OptumRx. Submit your prior authorization using:

Online Portal (Fastest)

  • UnitedHealthcare Provider Portal
  • Electronic submission typically processes within 15 business days

Fax Submission

  • Fax number: 1-844-403-1027
  • Include cover sheet with patient information and urgency level

Phone for Urgent Cases

  • Call 1-800-711-4555 for life-threatening situations
  • Urgent requests require decision within 24 hours

Complete Request Packet Checklist

Your submission should include:

  • Completed OptumRx Prior Authorization Form
  • Genetic test results (biallelic DDC mutations)
  • AADC enzyme activity or CSF analysis results
  • Clinical notes documenting symptoms and progression
  • Letter of medical necessity
  • Treatment center network confirmation
Tip: Submit through the electronic portal when possible. Electronic submissions process faster and provide real-time status updates.

Follow-Up and Timeline Expectations

Standard Processing Times

  • Electronic submissions: 15 business days maximum
  • Incomplete submissions: UnitedHealthcare must notify you within 3 business days of missing information
  • Urgent requests: 24 hours for life-threatening situations

How to Check Status

Call 1-800-711-4555 with your reference number to check status. Ask specifically:

  • Current status of the prior authorization
  • Any additional information needed
  • Expected decision timeline
  • Whether the case qualifies for expedited review

Sample Follow-Up Script

"Hi, I'm calling to check the status of a prior authorization for Upstaza gene therapy. The reference number is [number]. Can you tell me the current status and whether any additional information is needed?"

If You Need to Provide Additional Information

Common Requests for Additional Information

Genetic Testing Clarification

  • Specific mutation details if initial results were unclear
  • Additional genetic counseling notes
  • Family history documentation

Clinical Justification

  • More detailed symptom documentation
  • Progression timelines
  • Functional assessment results

Treatment Center Verification

  • Confirmation of surgeon qualifications
  • Center of excellence certification
  • Network participation status

How to Submit Additional Information

Respond promptly to requests for additional information:

  • Use the same submission method as your original request
  • Reference your original prior authorization number
  • Include a cover letter explaining what additional information you're providing

If Your Request is Denied

Common Denial Reasons and Solutions

Denial Reason How to Address
"Experimental/investigational" Provide FDA approval documentation from August 2024
"Genetic testing insufficient" Submit complete genetic panel showing biallelic DDC mutations
"Age requirements not met" Provide birth certificate showing patient is ≥18 months
"Non-network facility" Verify center participation or request network exception

First-Level Internal Appeal

You have 180 days from the denial date to file an internal appeal with UnitedHealthcare. Submit:

  • Written appeal letter addressing each denial reason
  • Additional clinical evidence
  • Peer-reviewed literature supporting treatment
  • Updated physician letter of medical necessity

Peer-to-Peer Review Request

Request a peer-to-peer review where your physician can speak directly with UnitedHealthcare's medical director. This often resolves denials based on medical necessity questions.

North Carolina Appeals Process

Smart NC External Review Program

North Carolina residents have access to Smart NC, a free external review program with strong success rates for specialty drug appeals.

Success Rates:

  • 81.7% overturn rate for specialty drug denials
  • 85% success with comprehensive documentation packages
  • Particularly effective for rare disease medications

How to Access Smart NC

Contact Information:

  • Phone: 1-855-408-1212
  • Free advocacy and guidance available
  • Staff can help complete external review forms

Eligibility Requirements:

  • Final internal denial from UnitedHealthcare received
  • State-regulated plan (most individual and small group plans qualify)
  • Denial based on medical necessity or experimental treatment determination

External Review Timeline

Standard Review: 45 days for decision Expedited Review: 72 hours for urgent cases

To Request Expedited Review:

  • Document that delay would seriously jeopardize health
  • Include physician statement about urgency
  • Submit request within 120 days of final internal denial

Documentation for Successful Appeal

Submit comprehensive evidence addressing the specific denial:

  • Complete genetic testing showing exact DDC mutations
  • Current enzyme assay results
  • Specialist consultation notes
  • Documentation of symptom progression without treatment
  • FDA approval documentation for Upstaza
From Our Advocates: Families who submit complete documentation packages—including genetic testing, enzyme activity results, and detailed clinical justification—typically see approval within 72 hours through electronic submission. The key is addressing each specific denial reason with targeted clinical evidence rather than resubmitting the same materials.

Renewal and Re-authorization

When to Start Renewal Process

Upstaza is a one-time gene therapy, so traditional renewal doesn't apply. However, you may need:

  • Pre-treatment authorization updates if delays occur
  • Post-treatment coverage for monitoring and follow-up care
  • Documentation for any additional procedures or complications

What to Include for Follow-Up Care

  • Post-treatment monitoring plans
  • Any complications or additional interventions needed
  • Long-term follow-up care requirements

Quick Reference Checklist

Before Submitting

  • Verify UnitedHealthcare coverage includes gene therapy
  • Confirm treatment center is in-network
  • Gather genetic testing results (biallelic DDC mutations)
  • Obtain enzyme activity or CSF analysis results
  • Collect clinical notes and physician letter

Submission Process

  • Complete OptumRx Prior Authorization Form
  • Submit through provider portal (fastest) or fax to 1-844-403-1027
  • Document reference number for follow-up
  • Set calendar reminder to check status in 5-7 business days

If Denied

  • Review denial letter for specific reasons
  • Gather additional evidence addressing each denial point
  • Submit internal appeal within 180 days
  • Contact Smart NC at 1-855-408-1212 for external review guidance
  • Consider peer-to-peer review request

Costs and Support Options

Manufacturer Support

PTC Therapeutics offers patient support through PTCcares. Contact them for:

  • Insurance navigation assistance
  • Financial assistance programs
  • Treatment center coordination

State Programs

North Carolina expanded Medicaid coverage effective 2024, which may provide additional options for eligible patients. Contact your local Department of Social Services for eligibility screening.

When to Escalate to State Regulators

If you've exhausted internal appeals and Smart NC external review without success, you can file a complaint with the North Carolina Department of Insurance. This is appropriate when:

  • UnitedHealthcare fails to meet processing deadlines
  • Procedural violations occur during the appeals process
  • Coverage decisions appear to violate state insurance laws

Contact the North Carolina Department of Insurance for complaint filing procedures.


About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to create point-by-point rebuttals with the right clinical evidence and procedural requirements for each payer.


Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for specific coverage decisions. Prior authorization requirements and appeal processes may change; verify current procedures with UnitedHealthcare and North Carolina regulators.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.